Affan A, Zurada J, Inanc T
IEEE Open J Eng Med Biol. 2023; 3:242-251.
PMID: 36846361
PMC: 9955254.
DOI: 10.1109/OJEMB.2023.3240072.
McDonnell J, Rigney B, Storme J, Ahern D, Cunniffe G, Butler J
Ir J Med Sci. 2022; 192(3):1215-1224.
PMID: 35962253
DOI: 10.1007/s11845-022-03112-9.
Daly A, Rettie A, Fowler D, Miners J
J Pers Med. 2017; 8(1).
PMID: 29283396
PMC: 5872075.
DOI: 10.3390/jpm8010001.
Wigle T, Jansen L, Teft W, Kim R
J Pers Med. 2017; 7(4).
PMID: 29236081
PMC: 5748632.
DOI: 10.3390/jpm7040020.
Mili F, Allen T, Wadell P, Hooper W, De Staercke C, Bean C
Future Cardiol. 2017; 14(1):15-26.
PMID: 29218998
PMC: 6727961.
DOI: 10.2217/fca-2017-0025.
Clinical and genetic factors associated with warfarin maintenance dose in northern Chinese patients with mechanical heart valve replacement.
Liu R, Cao J, Zhang Q, Shi X, Pan X, Dong R
Medicine (Baltimore). 2017; 96(2):e5658.
PMID: 28079798
PMC: 5266160.
DOI: 10.1097/MD.0000000000005658.
Pharmacogenetic Implementation Lessons From the "Real World".
Roden D
Clin Pharmacol Ther. 2016; 102(1):25-27.
PMID: 27981579
PMC: 5474210.
DOI: 10.1002/cpt.584.
Genome-wide association study of paliperidone efficacy.
Li Q, Wineinger N, Fu D, Libiger O, Alphs L, Savitz A
Pharmacogenet Genomics. 2016; 27(1):7-18.
PMID: 27846195
PMC: 5152628.
DOI: 10.1097/FPC.0000000000000250.
Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine.
Ahmed S, Zhou Z, Zhou J, Chen S
Genomics Proteomics Bioinformatics. 2016; 14(5):298-313.
PMID: 27729266
PMC: 5093856.
DOI: 10.1016/j.gpb.2016.03.008.
Warfarin Pharmacogenetics: New Life for an Old Drug.
Wen M, Lee M
Acta Cardiol Sin. 2016; 29(3):235-42.
PMID: 27122712
PMC: 4804835.
Personalized medicine in thrombosis: back to the future.
Nagalla S, Bray P
Blood. 2016; 127(22):2665-71.
PMID: 26847245
PMC: 4891951.
DOI: 10.1182/blood-2015-11-634832.
A multi-factorial analysis of response to warfarin in a UK prospective cohort.
Bourgeois S, Jorgensen A, Zhang E, Hanson A, Gillman M, Bumpstead S
Genome Med. 2016; 8(1):2.
PMID: 26739746
PMC: 4702374.
DOI: 10.1186/s13073-015-0255-y.
Pharmacogenomics and personalized medicine: a review focused on their application in the Chinese population.
Shu W, Li J, Wang X, Huang M
Acta Pharmacol Sin. 2015; 36(5):535-43.
PMID: 25891088
PMC: 4422945.
DOI: 10.1038/aps.2015.10.
Cardiovascular drugs and the genetic response.
Dandona S
Methodist Debakey Cardiovasc J. 2014; 10(1):13-7.
PMID: 24932357
PMC: 4051328.
DOI: 10.14797/mdcj-10-1-13.
Verification of pharmacogenetics-based warfarin dosing algorithms in Han-Chinese patients undertaking mechanic heart valve replacement.
Zhao L, Chen C, Li B, Dong L, Guo Y, Xiao X
PLoS One. 2014; 9(4):e94573.
PMID: 24728385
PMC: 3984158.
DOI: 10.1371/journal.pone.0094573.
Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon.
Verhoef T, Redekop W, Daly A, van Schie R, de Boer A, der Zee A
Br J Clin Pharmacol. 2013; 77(4):626-41.
PMID: 23919835
PMC: 3971980.
DOI: 10.1111/bcp.12220.
Factors affecting warfarin dose requirements and quality of anticoagulation in adult Egyptian patients: role of gene polymorphism.
Bazan N, Sabry N, Rizk A, Mokhtar S, Badary O
Ir J Med Sci. 2013; 183(2):161-72.
PMID: 23800980
DOI: 10.1007/s11845-013-0978-y.
Pharmacogenetics of warfarin: challenges and opportunities.
Lee M, Klein T
J Hum Genet. 2013; 58(6):334-8.
PMID: 23657428
PMC: 4074513.
DOI: 10.1038/jhg.2013.40.
Effect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarin.
Fung E, Patsopoulos N, Belknap S, ORourke D, Robb J, Anderson J
Semin Thromb Hemost. 2012; 38(8):893-904.
PMID: 23041981
PMC: 4134937.
DOI: 10.1055/s-0032-1328891.
Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysis.
Jorgensen A, FitzGerald R, Oyee J, Pirmohamed M, Williamson P
PLoS One. 2012; 7(8):e44064.
PMID: 22952875
PMC: 3430615.
DOI: 10.1371/journal.pone.0044064.
